These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2594922)

  • 41. Prenatal methylazoxymethanol treatment potentiates d-amphetamine- and methylphenidate-induced motor activity in male and female rats.
    Archer T; Fredriksson A; Sundström E; Luthman J; Lewander T; Söderberg U; Jonsson G
    Pharmacol Toxicol; 1988 Oct; 63(4):233-9. PubMed ID: 3194344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
    Ahlskog JE; Randall PK; Hernandez L; Hoebel BG
    Psychopharmacology (Berl); 1984; 82(1-2):118-21. PubMed ID: 6420820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unilateral mesolimbicocortical dopamine denervation decreases locomotion in the open field and after amphetamine.
    Jeste DV; Smith GP
    Pharmacol Biochem Behav; 1980 Mar; 12(3):453-7. PubMed ID: 7393946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat.
    Luthman J; Bolioli B; Tsutsumi T; Verhofstad A; Jonsson G
    Brain Res Bull; 1987 Aug; 19(2):269-74. PubMed ID: 3664282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal 6-hydroxydopamine potentiates clonidine's locomotor effects throughout maturation in the rat.
    Smythe JW; Pappas BA
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1075-8. PubMed ID: 3927324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.
    Olds ME; Fobes JL; Albert V
    Psychopharmacology (Berl); 1981; 73(1):31-3. PubMed ID: 6785786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity responses to morphine and amphetamine in rats with elevated NE levels in the pons.
    Olds ME; Fobes JL
    Pharmacol Biochem Behav; 1981 Aug; 15(2):167-71. PubMed ID: 7312890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
    Martin-Iverson MT; Leclere JF; Fibiger HC
    Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
    Fuchs V; Coper H
    Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infant rat hyperactivity elicited by home cage bedding is unaffected by neonatal telencephalic dopamine or norepinephrine depletion.
    Pappas BA; Vickers G; Buxton M; Pusztay W
    Pharmacol Biochem Behav; 1982 Jan; 16(1):151-4. PubMed ID: 6799968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pups.
    Wool RS; Weldon DA; Shaywitz BA; Anderson GM; Cohen DJ; Teicher MH
    Dev Psychobiol; 1987 Mar; 20(2):219-32. PubMed ID: 3108057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 56. Stereotyped behavior: effects of d-amphetamine and methylphenidate in the young rat.
    Roffman JL; Raskin LA
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1095-102. PubMed ID: 9408219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
    Easton N; Steward C; Marshall F; Fone K; Marsden C
    Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.